Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma

Accumulating evidence shows a close association between various types of bile acids (BAs) and hepatocellular carcinoma (HCC), and they have been revealed to affect tumor immune response and progression mainly by regulating Farnesoid X receptor (FXR). Nevertheless, the roles of Norcholic acid(NorCA)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yihang Gong, Kun Li, Yunfei Qin, Kaining Zeng, Jianrong Liu, Shaozhuo Huang, Yewu Chen, Haoyuan Yu, Wei Liu, Linsen Ye, Yang Yang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/4edb1c5afafa4b80a3d6fcaefbea4214
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4edb1c5afafa4b80a3d6fcaefbea4214
record_format dspace
spelling oai:doaj.org-article:4edb1c5afafa4b80a3d6fcaefbea42142021-11-30T11:23:09ZNorcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma2234-943X10.3389/fonc.2021.711448https://doaj.org/article/4edb1c5afafa4b80a3d6fcaefbea42142021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.711448/fullhttps://doaj.org/toc/2234-943XAccumulating evidence shows a close association between various types of bile acids (BAs) and hepatocellular carcinoma (HCC), and they have been revealed to affect tumor immune response and progression mainly by regulating Farnesoid X receptor (FXR). Nevertheless, the roles of Norcholic acid(NorCA) in HCC progression remain unknown yet. In this study, herein we demonstrate that NorCA can promote HCC cell proliferation, migration and invasion through negatively regulating FXR. Additionally, NorCA can increase PD-L1 level on the surfaces of HCC cells and their exosomes, and NorCA-induced exosomes dramatically dampen the function of CD4+T cells, thereby inducing an immunosuppressive microenvironment. Meanwhile, a negative correlation between PD-L1 and FXR expression in human HCC specimens was identified, and HCC patients with FXRlowPD-L1high expression exhibit a rather dismal survival outcome. Importantly, FXR agonist (GW4064) can synergize with anti-PD-1 antibody (Ab) to inhibit HCC growth in tumor-bearing models. Taken together, NorCA can promote HCC progression and immune invasion by inhibiting FXR signaling, implying a superiority of the combination of FXR agonist and anti‐PD‐1 Ab to the monotherapy of immune checkpoint inhibitor in combating HCC. However, more well-designed animal experiments and clinical trials are warranted to further confirm our findings in future due to the limitations in our study.Yihang GongYihang GongKun LiKun LiYunfei QinKaining ZengJianrong LiuShaozhuo HuangYewu ChenYewu ChenHaoyuan YuHaoyuan YuWei LiuWei LiuLinsen YeLinsen YeYang YangFrontiers Media S.A.articlehepatocellular carcinoma (HCC)bile acidsexosomesimmune microenvironmentFarnesoid X receptorNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic hepatocellular carcinoma (HCC)
bile acids
exosomes
immune microenvironment
Farnesoid X receptor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle hepatocellular carcinoma (HCC)
bile acids
exosomes
immune microenvironment
Farnesoid X receptor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Yihang Gong
Yihang Gong
Kun Li
Kun Li
Yunfei Qin
Kaining Zeng
Jianrong Liu
Shaozhuo Huang
Yewu Chen
Yewu Chen
Haoyuan Yu
Haoyuan Yu
Wei Liu
Wei Liu
Linsen Ye
Linsen Ye
Yang Yang
Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
description Accumulating evidence shows a close association between various types of bile acids (BAs) and hepatocellular carcinoma (HCC), and they have been revealed to affect tumor immune response and progression mainly by regulating Farnesoid X receptor (FXR). Nevertheless, the roles of Norcholic acid(NorCA) in HCC progression remain unknown yet. In this study, herein we demonstrate that NorCA can promote HCC cell proliferation, migration and invasion through negatively regulating FXR. Additionally, NorCA can increase PD-L1 level on the surfaces of HCC cells and their exosomes, and NorCA-induced exosomes dramatically dampen the function of CD4+T cells, thereby inducing an immunosuppressive microenvironment. Meanwhile, a negative correlation between PD-L1 and FXR expression in human HCC specimens was identified, and HCC patients with FXRlowPD-L1high expression exhibit a rather dismal survival outcome. Importantly, FXR agonist (GW4064) can synergize with anti-PD-1 antibody (Ab) to inhibit HCC growth in tumor-bearing models. Taken together, NorCA can promote HCC progression and immune invasion by inhibiting FXR signaling, implying a superiority of the combination of FXR agonist and anti‐PD‐1 Ab to the monotherapy of immune checkpoint inhibitor in combating HCC. However, more well-designed animal experiments and clinical trials are warranted to further confirm our findings in future due to the limitations in our study.
format article
author Yihang Gong
Yihang Gong
Kun Li
Kun Li
Yunfei Qin
Kaining Zeng
Jianrong Liu
Shaozhuo Huang
Yewu Chen
Yewu Chen
Haoyuan Yu
Haoyuan Yu
Wei Liu
Wei Liu
Linsen Ye
Linsen Ye
Yang Yang
author_facet Yihang Gong
Yihang Gong
Kun Li
Kun Li
Yunfei Qin
Kaining Zeng
Jianrong Liu
Shaozhuo Huang
Yewu Chen
Yewu Chen
Haoyuan Yu
Haoyuan Yu
Wei Liu
Wei Liu
Linsen Ye
Linsen Ye
Yang Yang
author_sort Yihang Gong
title Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
title_short Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
title_full Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
title_fullStr Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
title_full_unstemmed Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
title_sort norcholic acid promotes tumor progression and immune escape by regulating farnesoid x receptor in hepatocellular carcinoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/4edb1c5afafa4b80a3d6fcaefbea4214
work_keys_str_mv AT yihanggong norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT yihanggong norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT kunli norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT kunli norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT yunfeiqin norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT kainingzeng norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT jianrongliu norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT shaozhuohuang norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT yewuchen norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT yewuchen norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT haoyuanyu norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT haoyuanyu norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT weiliu norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT weiliu norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT linsenye norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT linsenye norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
AT yangyang norcholicacidpromotestumorprogressionandimmuneescapebyregulatingfarnesoidxreceptorinhepatocellularcarcinoma
_version_ 1718406681535184896